| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $89,877,720 ) (Continued on the next page) |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS131652 | CB1 receptors mediate metaplasticity in the cerebellar circuit | 000 | 1 | NIH | 2/29/2024 | $407,189 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG081709 | The role of medullary thymic epithelial cell-derived growth factors in regulating thymus growth and atrophy | 001 | 2 | NIH | 5/6/2024 | $19,375 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG081709 | The role of medullary thymic epithelial cell-derived growth factors in regulating thymus growth and atrophy | 000 | 2 | NIH | 12/1/2023 | $174,375 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 001 | 2 | NIH | 4/25/2024 | $39,672 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 2 | NIH | 1/16/2024 | $357,064 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21MH129960 | Behavioral state-dependent microglia Ca2+ dynamics | 001 | 2 | NIH | 7/9/2024 | $19,375 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21MH129960 | Behavioral state-dependent microglia Ca2+ dynamics | 000 | 2 | NIH | 12/29/2023 | $174,375 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 001 | 2 | NIH | 4/17/2024 | $26,448 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 000 | 2 | NIH | 12/14/2023 | $476,077 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172207 | Translational Regulation of Candida glabrata Azole Resistance | 001 | 2 | NIH | 6/5/2024 | $23,250 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172207 | Translational Regulation of Candida glabrata Azole Resistance | 000 | 2 | NIH | 12/7/2023 | $209,250 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK135179 | Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD | 001 | 2 | NIH | 5/15/2024 | $31,495 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK135179 | Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD | 000 | 2 | NIH | 12/27/2023 | $472,438 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA055703 | Uptake2 transporters: Novel sex-dependent molecular targets to treat stimulant use disorder | 000 | 2 | NIH | 5/22/2024 | $680,812 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA057787 | Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia | 000 | 2 | NIH | 7/11/2024 | $508,286 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8837558 | Postdoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene | 00 | 5 | HRSA | 5/13/2024 | $260,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI181573 | Identifying a Critical Gatekeeper for DNA Virus Restriction | 000 | 1 | NIH | 7/22/2024 | $38,494 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Embryonal Rhabdomyosarcoma | 001 | 3 | NIH | 4/17/2024 | $17,729 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Embryonal Rhabdomyosarcoma | 000 | 3 | NIH | 1/22/2024 | $319,106 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279681 | Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer. | 000 | 1 | NIH | 11/27/2023 | $439,997 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA277399 | Development of a new class of EZH2 inhibitors in ERa-negative breast cancer. | 000 | 1 | NIH | 12/20/2023 | $213,194 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 1 | NIH | 11/29/2023 | $192,844 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32TR004545 | CTSA Predoctoral T32 at The University of Texas Health Science Center at San Antonio | 000 | 2 | NIH | 7/19/2024 | $274,584 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 001 | 5 | NIH | 4/17/2024 | $17,699 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 000 | 5 | NIH | 12/22/2023 | $318,547 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA237159 | Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue | 001 | 5 | NIH | 4/16/2024 | $17,729 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA237159 | Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue | 000 | 5 | NIH | 1/23/2024 | $319,106 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 000 | 30 | NIH | 12/14/2023 | $505,540 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA005018 | Discriminative Stimulus Effects of Opioid Withdrawal | 001 | 35 | NIH | 4/25/2024 | $64,237 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA005018 | Discriminative Stimulus Effects of Opioid Withdrawal | 000 | 35 | NIH | 12/18/2023 | $578,128 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01EY012085 | Intercellular Communication in the Eye Lens | 002 | 26 | NIH | 1/10/2024 | $433,022 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 002 | 1 | NIH | 5/13/2024 | $1,280 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 001 | 1 | NIH | 2/1/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 1 | NIH | 12/20/2023 | $37,034 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 000 | 4 | NIH | 1/24/2024 | $604,736 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG070214 | The role of CELF2 and its genetic variants in Alzheimer's disease | 001 | 4 | NIH | 6/10/2024 | $45,105 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG070214 | The role of CELF2 and its genetic variants in Alzheimer's disease | 000 | 4 | NIH | 1/15/2024 | $405,951 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25NS115552 | Summer Physiology Undergraduate Researcher (SPUR) Program | 000 | 4 | NIH | 11/17/2023 | $107,680 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153506 | IL-27-producing B cells in the antibody response | 001 | 4 | NIH | 5/28/2024 | $44,486 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153506 | IL-27-producing B cells in the antibody response | 000 | 4 | NIH | 12/20/2023 | $400,365 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 002 | 4 | NIH | 5/31/2024 | $54,367 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 001 | 4 | NIH | 1/23/2024 | $10,750 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 000 | 4 | NIH | 1/12/2024 | $489,300 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140456 | Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome | 001 | 4 | NIH | 6/12/2024 | $31,000 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140456 | Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome | 000 | 4 | NIH | 12/11/2023 | $279,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 001 | 4 | NIH | 6/6/2024 | $45,246 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 000 | 4 | NIH | 1/18/2024 | $407,215 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL158081 | Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology | 000 | 3 | NIH | 11/24/2023 | $310,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 001 | 3 | NIH | 6/17/2024 | $57,966 |
|